A survey on Swiss women's preferred menstrual/withdrawal bleeding pattern over different phases of reproductive life and with use of hormonal contraception

REFERENCES

• Lin K, Barnhart K. The clinical rationale for menses-free contraception. J Womens Health (Larchmt) 2007; 16:1171–80.
   PubMed Web of Science ®Google Scholar
• Wong LP. Attitudes toward menstruation, menstrual-related symptoms, and premenstrual syndrome among adolescent girls: A rural school-based survey. Women Health 2011;51:340–64.
   PubMed Web of Science ®Google Scholar
• Houston AM, Abraham A, Huang Z, D’Angelo LJ. Knowledge, attitudes, and consequences of menstrual health in urban adolescent females. J Pediatr Adolesc Gynecol 2006;19:271–5.
   PubMedGoogle Scholar
• Fruzzetti F, Paoletti AM, Lombardo M, et al. Attitudes of Italian women concerning suppression of menstruation with oral contraceptives. Eur J Contracept Reprod Health Care 2008;13:153–7.
   PubMed Web of Science ®Google Scholar
• McEvoy M, Chang J, Coupey SM. Common menstrual disorders in adolescence: Nursing interventions. MCN Am J Matern Child Nurs 2004;29:41–9.
   PubMedGoogle Scholar
• Sulak PJ, Cressman BE, Waldrop E, et al. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms. Obstet Gynecol 1997;89:179–83.
   PubMed Web of Science ®Google Scholar
• Picardo CM, Nichols M, Edelman A, et al. Women's knowledge and sources of information on the risks and benefits of oral contraception. J Am Med Womens Assoc 2003;58:112–16.
   PubMedGoogle Scholar
• Archer DF, Jensen JT, Johnson JV, et al. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: Phase 3 study results. Contraception 2006;74:439–45.
   PubMed Web of Science ®Google Scholar
• Edelman A, Lew R, Cwiak, et al. Acceptability of contraceptive-induced amenorrhea in a racially diverse group of US women. Contraception 2007;75:450–3.
   PubMed Web of Science ®Google Scholar
• den Tonkelaar I, Oddens BJ. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. Contraception 1999;59: 357–62.
   PubMed Web of Science ®Google Scholar
• Glasier AF, Smith KB, van der Spuy ZM, et al. Amenorrhea associated with contraception – an international study on acceptability. Contraception 2003;67:1–8.
   PubMed Web of Science ®Google Scholar
• Andrist LC, Arias RD, Nucatola D, et al. Women's and providers’ attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception 2004;70:359–63.
   PubMed Web of Science ®Google Scholar
• Hitchcock CL, Prior JC. Evidence about extending the duration of oral contraceptive use to suppress menstruation. Womens Health Issues 2004;14:201–11.
   PubMed Web of Science ®Google Scholar
• Wiegratz I, Hommel HH, Zimmermann T, et al. Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception 2004;69:37–42.
   PubMed Web of Science ®Google Scholar
• Makuch MY, Osis MJ, Petta CA, et al. Menstrual bleeding: Perspective of Brazilian women. Contraception 2011;84:622–27.
   PubMed Web of Science ®Google Scholar
• Szarewski A, von Stenglin A, Rybowski S. Women's attitudes towards monthly bleeding: Results of a global population-based survey. Eur J Contracept Reprod Health Care 2012;17:270–83.
   PubMed Web of Science ®Google Scholar
• Snow R, Hardy E, Kneuper E, et al. Women's responses to menses and nonbleeding intervals in the USA, Brazil and Germany. Contraception 2007;76:23–9.
   PubMed Web of Science ®Google Scholar
• Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhoea in young women. Br J Obstet Gynaecol 1990;97:588–94.
   PubMedGoogle Scholar
• Clark LR, Barnes-Harper KT, Ginsburg KR, et al. Menstrual irregularity from hormonal contraception: A cause of reproductive health concerns in the minority of adolescent young women. Contraception 2006;74:214–9.
   PubMed Web of Science ®Google Scholar
• Loudon NB, Kirkman RJ, Dewsbury JA. A double-blind comparison of the efficacy and acceptability of Femodene and Microgynon-30. Eur J Obstet Gynecol Reprod Biol 1990;34:257–66.
   PubMed Web of Science ®Google Scholar
• Bassol S, Alvarado A, Celis C, et al. Latin American experience with two low-dose oral contraceptives containing 30 microg ethinylestradiol/75 microg gestodene and 20 microg ethinylestradiol/150 microg desogestrel. Contraception 2000;62:131–5.
   PubMed Web of Science ®Google Scholar
• Akerlund M, Rode A, Westergaard J. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol. Br J Obstet Gynaecol 1993;100:832–8.
   PubMedGoogle Scholar
• Anderson FD, Gibbons W, Portman D. Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol. Contraception 2006;73:229–34.
   PubMed Web of Science ®Google Scholar
• Seidman DS, Yeshaya A, Ber A, et al. A prospective follow-up of two 21/7 cycles followed by two extended regimen 84/7 cycles with contraceptive pills containing ethinyl estradiol and drospirenone. Isr Med Assoc J 2010;12:400–5.
   PubMed Web of Science ®Google Scholar
• Miller L, Hughes JP. Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: A randomized trial. Obstet Gynecol 2003;101:653–61.
   PubMed Web of Science ®Google Scholar
• Guazzelli CA, Barreiros FA, Barbosa R, et al. Extended regimens of the vaginal contraceptive ring: Cycle control. Contraception 2009;80:430–5.
   PubMed Web of Science ®Google Scholar
• Anderson FD, Gibbons W, Portman D. Long-term safety of an extended-cycle oral contraceptive (Seasonale): A 2-year multicenter open-label extension trial. Am J Obstet Gynecol 2006;195:92–6.
   PubMed Web of Science ®Google Scholar
• Westhoff C, Kaunitz AM, Korver T, et al. Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17beta-estradiol: A randomized controlled trial. Obstet Gynecol 2012;119:989–99.
   PubMed Web of Science ®Google Scholar
• Ahrendt HJ, Makalova D, Parke S, et al. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: A seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel. Contraception 2009;80:436–44.
   PubMed Web of Science ®Google Scholar